References
- Russo A, Schiliro G. Thalassemia major and malignancies. Am J Hematol 1987; 24(1)111–112
- Dash S, Punnose J, Dash R J. Monoclonal gammopathy in β thalassemia. Jpn J Med 1986; 25(1)57–58
- Fabris P, Coser P, Prinoth O. Multiple myeloma terminating in acute myeloid leukemia in a patient with a β‐thalassemia trait. A case report. Haematologica 1977; 62(6)629–636
- Kaloterakis A, Filiotou A, Konstantopoulos K, Rombos Y, Bossinakou I, Hadziyannis S. Multiple myeloma in sickle cell syndromes. Haematologica (Budapest) 2001; 31(2)153–159
- Miniero R, Saracco P. Cancer in thalassemia and other hemoglobinopathies. Am J Hematol 1988; 27(1)74
- Stricker R B, Linker C A, Crowley T J, Embury S H. Hematologic malignancy in sickle cell disease: report of four cases and review of the literature. Am J Hematol 1986; 21(2)223–230
- Zurlo M G, De Stefano P, Borgne‐Pignatti C, Di Palma A, Melevendi C, Di Gregorio F, Burattini M G, Terzoli S. Survival and causes of death in thalassemia major. Lancet 1989; 2(8653)27–30
- Das Gupta A, Nair L, Shah A, Barbhaya S A. Association of hematologic malignancies with hemoglobinopathies. Am J Hematol 1988; 28(2)130–131
- Miniero R, Pastore G, Saracco P, Terracini B. Homozygous β‐thalassemia and cancer. Haematologica 1985; 70(1)78–79
- Bering H A, Duttaguptor S, Lebowitz P. Proto‐oncogene expression during erythoid proliferation. Clin Res 1984; 32: 304A, (abstr.)
- Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper–suppressor lymphocyte ratio and natural killer activity in recipients of repeated blood transfusions. Blood 1984; 64(1)308–310
- Stevens R G, Jones D Y, Micozzi M S, Taylor P R. Body iron stores and the risk of cancer. N Engl J Med 1988; 319(16)1047–1052
- Balistrazzi P, Butturini A. Thalassemia and Hodgkin lymphoma. Blut 1985; 50(1)55
- Chehal A, Loutfi R, Taher A. β‐Thalassemia intermedia and non‐Hodgkin's lymphoma. Hemoglobin 2002; 26(3)219–225